Indicateurs | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Chiffre d'affaires | 56,16 M € | 32,36 M € | 100,77 M € | 114,05 M € | 22,70 M € | 29,69 M € | 50,19 M € | 56,36 M € | 17,81 M € |
Marge brute | 53,31 M € | 28,07 M € | 104,65 M € | 110,73 M € | 19,09 M € | 26,28 M € | 46,90 M € | 53,84 M € | 15,12 M € |
Résultat d'exploitation | -685,00 k € | -41,50 M € | -1,30 M € | 4,00 M € | -47,23 M € | -52,05 M € | -73,91 M € | -18,67 M € | -56,12 M € |
EBITDA - EBE | 3,14 M € | -36,40 M € | 196,36 M € | 18,59 M € | -37,77 M € | -48,68 M € | -28,58 M € | -15,20 M € | -54,18 M € |
Résultat net | 13,07 M € | -38,76 M € | 11,44 M € | 22,12 M € | -119,27 M € | -42,30 M € | -63,31 M € | -7,16 M € | -45,34 M € |
Indicateurs | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Chiffre d'affaires | -42.38 % | 211.42 % | 13.17 % | -80.1 % | 30.81 % | 69.02 % | 12.3 % | -68.4 % |
Marge brute | -47.34 % | 272.76 % | 5.81 % | -82.76 % | 37.64 % | 78.48 % | 14.78 % | -71.92 % |
Marge d'EBITDA | 5958.69 % | -96.87 % | -408.32 % | -1280.21 % | 10.2 % | 42.01 % | -74.74 % | 200.54 % |
Marge opérationnelle | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % |
En activité
En activité
Fermé
Fermé
Fermé
13/08/2025
2024 - Comptes complets03/06/2025
2023 - Comptes consolidés03/06/2025
2023 - Comptes complets14/05/2025
CA_424365336_1303_K00144497195_2023_K14/05/2025
CA_424365336_1303_K00144489127_2023_C15/06/2023
CA_424365336_1303_1999B01940_2022_495515/06/2023
CA_424365336_1303_1999B01940_2022_495723/06/2022
CA_424365336_1303_1999B01940_2021_809422/06/2022
CA_424365336_1303_1999B01940_2021_793806/07/2021
CA_424365336_1303_1999B01940_2020_1271006/07/2021
CA_424365336_1303_1999B01940_2020_1271206/07/2020
CA_424365336_1303_1999B01940_2019_888806/07/2020
CA_424365336_1303_1999B01940_2019_888921/06/2019
CA_424365336_1303_1999B01940_2018_570821/06/2019
CA_424365336_1303_1999B01940_2018_570607/01/2019
CA_424365336_1303_1999B01940_2017_14525/06/2018
CA_424365336_1303_1999B01940_2017_706009/03/2026
20260303_Innate_Pharma_Statuts_Draft.pdf13/02/2026
20260109_Innate_Pharma_Statuts.pdf13/01/2026
20260109_Innate_Pharma_Statuts.pdf07/01/2026
20251127_Innate_Pharma_Statuts.pdf23/12/2025
20251127_Innate_Pharma_Statuts_Draft.pdf10/12/2025
20251127_Innate_Pharma_Statuts.pdf24/11/2025
2_20251118_Innate_Pharma_Statuts.pdf22/09/2025
2_20250818_Innate_Pharma_Statuts.pdf18/09/2025
2_20250731_Innate_Pharma_Statuts.pdf17/09/2025
2_20250717_Innate_Pharma_Statuts.pdf29/07/2025
Innate_Pharma_-_Statuts_22_mai_2025.pdf15/07/2025
2_20250703_Innate_Pharma_Statuts.pdf23/05/2025
2024_05_23_PV_AGM_Innate_Pharma_2.pdf23/02/2009
rqchKz8SbK7u_RACT090154357323/02/2009
bb6vQ0OGhr7n_RACT090154357110/09/2008
R2NoQC5lV9Vc_RACT080022962426/06/2008
EpAf38S5qok2_RACT080009213921/02/2008
gajBh1AtGI4i_RACT080030940715/11/2007
CNKzQmGFWEbX_RACT070053847726/10/2007
WoieBR8vkMUp_RACT070132419020/06/2007
tIBdLAdcj3FX_RACT070020256116/04/2007
fOq0myZbyKhK_RACT070042683727/02/2007
J6x3Ca6WzEzE_RACT070106600502/01/2007
zqOle873XHDh_RACT070030585030/11/2006
p5XRO8tGe36w_RACT060300464830/11/2006
vLQR94OXCS0k_RACT060300464920/10/2006
6eDZM9MmlCLe_RACT060103275805/10/2006
TNz5A1ZjoeuL_RACT060095447006/07/2006
HbxwrH7EPyee_RACT060068720727/04/2006
u3h1tWbDZFOT_RACT060076648509/08/2005
yIstaFPy9XdN_RACT050062939309/08/2005
plpcqq3M0Z0s_RACT050062939113/06/2005
9EQ0Pr5IcMgl_RACT050111344406/06/2005
PAXlfVUIRow3_RACT050002037229/09/2004
op0OHiT7ZSMN_RACT040015480226/04/2004
4ILgDSVwhXLl_RACT040038940709/02/2004
h3muBtWBp8JM_RACT040030659015/10/2002
HrE3rpdchkdE_RACT020098691102/10/2002
yzkJYWUydu2s_RACT020100512215/03/2002
QzW81njcwvUW_RACT020043947327/08/2001
RXnrsTWbTAaG_RACT010039658317/08/2000
G0nVYdDPfQnn_RACT000063821920/06/2000
b5k4By5p4tWk_RACT000021063717/04/2000
WfLn9702JKJ0_RACT000065003317/04/2000
FV98Ec2dScAx_RACT000072618212/04/2000
yfV1oHKQiLbr_RACT000037800323/09/1999
ZZ6OrOgP4rUE_RACT990063331804/06/2025
2024_05_23_PV_AGM_Innate_Pharma_223/01/2003
h01LXvJyXxa3_RACT0300045809